Biophytis Set to Participate in International Events Across Europe and the US

Biophytis SA, a Paris and Cambridge-based biotechnology firm focusing on age-related diseases, has announced its plan to attend several significant conferences in Europe and the United States up until the end of June 2024. The company, known for pioneering therapeutics designed to slow down degenerative aging processes, aims to showcase its recent developments and foster connections within the global biopharmaceutical community.

At the 14th International Conference on Frailty and Sarcopenia Research in Albuquerque, from March 20 to 22, Biophytis will engage with key researchers and physicians in the field of sarcopenia. Further, the company will participate in the BIO-Europe Spring in Barcelona from March 18 to 20, the Pharma Partnering Summit in Basel on May 22 and 23, and the BIO International Convention in San Diego from June 3 to 6. These events provide platforms for Biophytis to present its advancements, interact with investors, and explore potential pharmaceutical partnerships.

With over 2,000 companies and 3,700 participants, BIO-Europe Spring is notably the early-year event focusing on life sciences partnerships. Similarly, the Pharma Partnering Summit and BIO International Convention are significant events, the latter attracting over 20,000 business leaders, emphasizing the industry's commitment to innovation and collaboration.